Aethlon Medical, Inc.
AEMD
$0.4361
-$0.0139-3.09%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -32.65% | -8.60% | -23.10% | -18.20% | -5.46% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -32.65% | -8.60% | -23.10% | -18.20% | -5.46% |
| Operating Income | 32.65% | 8.60% | 23.10% | -0.76% | 5.46% |
| Income Before Tax | 49.37% | 7.50% | 21.66% | 1.68% | -21.63% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 49.37% | 7.50% | 21.66% | 1.68% | -21.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 49.37% | 7.50% | 21.66% | 1.68% | -21.63% |
| EBIT | 32.65% | 8.60% | 23.10% | -0.76% | 5.46% |
| EBITDA | 33.50% | 8.68% | 23.60% | -0.52% | 6.09% |
| EPS Basic | 90.87% | 83.52% | 74.46% | 13.95% | -10.91% |
| Normalized Basic EPS | 87.80% | 83.51% | 74.46% | 13.56% | 17.02% |
| EPS Diluted | 90.87% | 83.52% | 74.46% | 13.95% | -10.91% |
| Normalized Diluted EPS | 87.80% | 83.51% | 74.46% | 13.56% | 17.02% |
| Average Basic Shares Outstanding | 454.83% | 461.19% | 206.72% | 14.26% | 9.67% |
| Average Diluted Shares Outstanding | 454.83% | 461.19% | 206.72% | 14.26% | 9.67% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
